Allen Holding Inc.
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 7, 2024), Allen Holding Inc. reported 14 stock positions worth $794.6 million. Its top holding was Coca-Cola (KO) at 46.2% of the portfolio, followed by Berkshire Hathaway Class A (BRK.A, 29.8%) and Palantir Technologies Class A (PLTR, 8.0%). Compared with Q4 2023, it added to 1. The biggest buy was Pfizer (PFE, shares +150%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0000919489
- Portfolio Value
- $794.6M (Q1 2024)
- SEC Filing
- 0001214659-24-008472 ↗ filed May 7, 2024
Holdings Value
Holdings 14 stocks · $794.6M
| KO The Coca-Cola Co. | 46.19% | 6,000,000 | $367.1M | No change |
| BRK.A Berkshire Hathaway Inc. Class A | 29.78% | 373 | $236.6M | No change |
| PLTR Palantir Technologies Inc. Class A | 7.96% | 2,750,000 | $63.3M | No change |
| PPLI People Inc. filed as IAC INC | 5.03% | 750,000 | $40.0M | No change |
| BAC Bank of America Corp. filed as BANK AMERICA CORP | 5.01% | 1,050,000 | $39.8M | No change |
| PFE Pfizer Inc. | 1.75% | 500,000 | $13.9M | Add +150.0% |
| AFRM Affirm Holdings Inc. | 1.20% | 255,262 | $9.5M | No change |
| JPM JPMorgan Chase & Co. | 0.76% | 30,000 | $6.0M | No change |
| TRIP Tripadvisor Inc. | 0.64% | 181,826 | $5.1M | No change |
| ANGI Angi Inc. | 0.56% | 1,700,000 | $4.5M | No change |
| IBRX Immunitybio Inc. | 0.46% | 687,571 | $3.7M | No change |
| VMEO Vimeo Inc. | 0.25% | 487,049 | $2.0M | No change |
| MTCH Match Group Inc. | 0.21% | 45,000 | $1.6M | No change |
| AGX Argan Inc. | 0.20% | 31,716 | $1.6M | No change |
Portfolio Sells Q4 2023 → Q1 2024
| None this quarter. | |||
Portfolio Buys Q4 2023 → Q1 2024
| PFE Pfizer Inc. | Add +150.0% | 1.75% | +0.94 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $1.0B | KO, BRK.A, PLTR, PFE, PPLI |
| Q1 2026 | 9 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q4 2025 | 9 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q3 2025 | 9 | $1.1B | KO, PLTR, BRK.A, PFE, PPLI |
| Q2 2025 | 10 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q1 2025 | 14 | $961.1M | KO, BRK.A, PLTR, PPLI, PFE |
| Q4 2024 | 14 | $911.8M | KO, BRK.A, PLTR, PFE, PPLI |
| Q3 2024 | 14 | $927.1M | KO, BRK.A, PLTR, BAC, PPLI |
| Q2 2024 | 14 | $800.3M | KO, BRK.A, PLTR, BAC, PPLI |
| Q1 2024 | 14 | $794.6M | KO, BRK.A, PLTR, PPLI, BAC |